Business Context and Reporting Period
Company: Danaher Corporation (DHR)
Filing Type: Form 8-K (Current Report)
Report Date: February 16, 2026 (Event Date: February 16, 2026; Filing Date: February 17, 2026)
Context: Danaher announced the entry into a definitive Agreement and Plan of Merger to acquire Masimo Corporation.
Key Financial Metrics and Transaction Terms
This filing is a current report regarding a corporate event and does not contain Danaher's periodic financial statements (revenue, profit, cash flow, or margins). The primary financial data provided relates to the proposed acquisition:
- Acquisition Target: Masimo Corporation
- Consideration: $180.00 per share in cash
- Payment Terms: Cash, without interest
- Structure: Merger Sub (wholly owned subsidiary of Danaher) will merge with and into Masimo; Masimo will survive as a wholly owned subsidiary.
Debt and Liquidity: The filing lists Danaher's registered securities, including various Senior Notes due between 2026 and 2049, but does not provide specific outstanding debt balances or liquidity metrics for the reporting period.
Material Changes and Conditions
The material change is the initiation of the merger transaction. Consummation of the Merger is subject to customary conditions, including:
- Expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976.
- Receipt of certain non-U.S. antitrust and foreign direct investment approvals.
- Approval by Masimo's stockholders.
Guidance, Outlook, Risks, and Contingencies
Outlook: Management expects the transaction to proceed subject to the satisfaction of closing conditions. No specific financial guidance or synergy targets are detailed in this specific filing.
Risks and Contingencies: The filing includes a comprehensive cautionary statement regarding forward-looking statements. Key risks include:
- Failure to obtain required regulatory approvals (U.S. and non-U.S.).
- Failure to obtain Masimo stockholder approval.
- Competing offers or acquisition proposals for Masimo.
- Termination of the merger agreement, potentially triggering termination fees.
- Disruption to ongoing business operations and retention of key personnel.
- Stockholder litigation costs and liabilities.
- Adverse effects on the market price of securities for both companies.
Investor Verification Checklist
- Verify the final approval status of the transaction by Masimo stockholders via the upcoming proxy statement.
- Monitor regulatory filings for the expiration of the HSR waiting period and receipt of foreign direct investment approvals.
- Review the definitive proxy statement for details on termination fees and specific conditions to closing.
- Assess the impact of the $180.00 per share cash consideration on Danaher's future liquidity and capital structure (not detailed in this 8-K).
- Check for any competing bids for Masimo that may alter the transaction terms.